严重喘中类固醇诱导的并发病的经济影响:一个SHARP CRC模拟
Barbara Mascialino1, Aruna T Bansal2, Elisabeth Bel3
1GSK, Verona, Italy.
ERJ open research
|November 19, 2025
概括
在严重喘 (SA) 患者中减少口服皮质类固醇 (OCS) 的使用,可以显著降低医疗保健成本. 停止OCS可以从与OCS相关的不良事件 (AE) 中获得长期的大幅度节省.
科学领域:
- 药物经济学 药物经济学
- 呼吸系统医学 呼吸系统医学
- 卫生经济学 卫生经济学
背景情况:
- 严重喘 (SA) 患者占全球喘医疗保健成本的50%,主要是由于口服皮质类固醇 (OCS) 相关的不良事件 (AE).
- 喘指南建议尽量减少OCS的使用,因为相关的风险.
- 生物制剂是持续OCS治疗的替代方案.
研究的目的:
- 模拟11个欧洲国家的SA患者中与OCS相关的AE的10年经济负担.
- 评估与OCS节约策略相关的成本节约.
主要方法:
- 为每个国家开发了一个预算影响模型,以估计SA患者的AE成本.
- 场景涉及不同百分比的患者每年停止OCS.
- 费用是基于文献数据的OCS-AE流行和相关支出.
主要成果:
- 在10年内,OCS相关的并发症的潜在成本降低率从13.1%到31.6%不等.
- 储蓄受到伴随性疾病发病率,OCS伴随性疾病可逆性以及停止OCS治疗的患者比例的影响.
结论:
- 在SA患者中停止OCS提供了长期不良事件成本降低的显著潜力.
- 这突显了OCS节约方法在治疗严重喘方面的经济效益.
更多相关视频
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
COPD: Management Using Bronchodilators and Corticosteroids
706
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
706
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K


